, Report on global monitoring, WHO. Susceptibility of Plasmodium falciparum to antimalarial drugs, 1996.

, World Health Organization, WHO. Global report on antimalarial efficacy and drug resistance, 2000.

E. Tjitra, N. M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem et al., Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, PLoS Med, vol.5, p.128, 2008.

R. N. Price, L. Von-seidlein, N. Valecha, F. Nosten, J. K. Baird et al., Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, vol.14, pp.982-91, 2014.

R. J. Commons, K. Thriemer, G. Humphreys, I. Suay, C. H. Sibley et al., The Vivax Surveyor: online mapping database for Plasmodium vivax clinical trials, Int J Parasitol, vol.7, pp.181-90, 2017.

M. D. Young and D. V. Moore, Chloroquine resistance in Plasmodium falciparum, Am J Trop Med Hyg, vol.10, pp.317-337, 1961.

D. E. Eyles, C. C. Hoo, M. Warren, and A. A. Sandosham, Plasmodium falciparum resistant to chloroquine in Cambodia, Am J Trop Med Hyg, vol.12, pp.840-843, 1963.

W. H. Wernsdorfer, Epidemiology of drug resistance in malaria, Acta Trop, vol.56, pp.143-56, 1994.

T. Mita, K. Tanabe, and K. Kita, Spread and evolution of Plasmodium falciparum drug resistance, Parasitol Int, vol.58, pp.201-210, 2009.

. Wwarn, . Wwarn, and . Surveyor, , 2017.

W. Höfler, Sulfadoxine-pyrimethamine resistant falciparum malaria from Cambodia, Dtsch Med Wochenschr, vol.105, pp.350-351, 1980.

E. S. Hurwitz, D. Johnson, and C. C. Campbell, Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand, Lancet, vol.1, pp.1068-70, 1981.

A. M. Mccollum, A. C. Poe, M. Hamel, C. Huber, Z. Zhou et al., Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles, J Infect Dis, vol.194, pp.189-97, 2006.

R. J. Pearce, H. Pota, M. Evehe, E. Bâ, G. Mombo-ngoma et al., Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria, PLoS Med, vol.6, p.1000055, 2009.

V. Lumb, M. K. Das, N. Singh, V. Dev, W. Khan et al., Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India, Antimicrob Agents Chemother, vol.55, pp.2813-2820, 2011.

M. T. Alam, S. Vinayak, K. Congpuong, C. Wongsrichanalai, W. Satimai et al., Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand, Antimicrob Agents Chemother, vol.55, pp.155-64, 2011.

C. Roper, R. Pearce, S. Nair, B. Sharp, F. Nosten et al., Intercontinental spread of pyrimethamine-resistant malaria, Science, vol.305, p.1124, 2004.

E. F. Boudreau, H. K. Webster, K. Pavanand, and L. Thosingha, Type II mefloquine resistance in Thailand, Lancet, vol.2, p.1335, 1982.

F. M. Smithuis, J. B. Van-woensel, E. Nordlander, W. S. Vantha, and F. O. Ter-kuile, Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother, vol.37, pp.1977-81, 1993.

N. J. White, Qinghaosu in combinations. Med Trop, vol.58, pp.85-93, 1998.

N. J. White, Preventing antimalarial drug resistance through combinations, Drug Resist Updates, vol.1, pp.3-9, 1998.

E. A. Ashley and N. J. White, Artemisinin-based combinations, Curr Opin Infect Dis, vol.18, pp.531-537, 2005.

, Guidelines for the treatment of malaria. Geneva, World Health Organization, 2010.

, WorldWide Antimalarial Resistance Network (WWARN) DP Study Group. The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data, PLoS Med, vol.10, p.1001564, 2013.

, Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data, Lancet Infect Dis, vol.15, pp.692-702, 2015.

M. A. Adjuik, R. Allan, A. R. Anvikar, E. A. Ashley, and M. S. Ba, The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, BMC Med, vol.13, p.66, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02560653

A. M. Dondorp, F. Nosten, P. Yi, D. Das, A. P. Phyo et al., Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02427334

H. Noedl, Y. Se, S. Sriwichai, K. Schaecher, P. Teja-isavadharm et al., Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia, Clin Infect Dis, vol.51, pp.82-91, 2010.

E. A. Ashley, M. Dhorda, R. M. Fairhurst, C. Amaratunga, P. Lim et al., Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, pp.411-434, 2014.

D. L. Saunders, P. Vanachayangkul, and C. Lon, Dihydroartemisinin-piperaquine failure in Cambodia, N Engl J Med, vol.371, pp.484-489, 2014.

V. Duru, B. Witkowski, and D. Menard, Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia, Am J Trop Med Hyg, vol.95, pp.1228-1266, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02560596

D. Menard and A. Dondorp, Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect Med, vol.7, p.25619, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02559309

F. Ariey, B. Witkowski, C. Amaratunga, J. Beghain, A. Langlois et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

J. Straimer, N. F. Gnadig, B. Witkowski, C. Amaratunga, V. Duru et al., K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates, Science, vol.347, pp.428-459, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01925134

D. Ménard, N. Khim, J. Beghain, A. A. Adegnika, M. Shafiul-alam et al., A worldwide map of Plasmodium falciparum K13-propeller polymorphisms, N Engl J Med, vol.374, pp.2453-64, 2016.

S. M. Chenet, A. Okoth, S. Huber, C. S. Chandrabose, J. Lucchi et al., Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana, J. Infect. Dis, vol.213, pp.1472-1477, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02862975

S. Takala-harrison, C. G. Jacob, C. Arze, M. P. Cummings, J. C. Silva et al., Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, J Infect Dis, vol.211, pp.670-679, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02560668

C. J. Woodrow and N. J. White, The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread, FEMS Microbiol Rev, vol.41, pp.34-48, 2017.

T. Wells, R. Hooft-van-huijsduijnen, V. Voorhis, and W. C. , Malaria medicines: a glass half full?, Nat Rev Drug Discov, vol.14, pp.424-466, 2015.

A. S. Bhagavathula, A. A. Elnour, and A. Shehab, Alternatives to currently used antimalarial drugs: in search of a magic bullet, Infect Dis Poverty, vol.5, p.103, 2016.

R. N. Price, G. Dorsey, E. A. Ashley, K. I. Barnes, J. K. Baird et al., World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs, Malar J, vol.6, p.119, 2007.

H. Tinto, I. Valea, J. Ouédraogo, and T. R. Guiguemdé, Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso, Ann Parasitol, vol.62, pp.17-24, 2016.

, Minutes of the Evidence Review Group meeting on the emergence and spread of multidrug-resistant Plasmodium falciparum lineages in the Greater Mekong subregion. Geneva, World Health Organization, 2016.

, Methods for surveillance of antimalarial drug efficacy. Geneva, World Health Organization, 2009.

, Report of a WHO scientific group. Geneva, World Health Organization, 1965.

, Assessment of therapeutic efficacy of antimalarial drugs. for uncomplicated falciparum malaria in areas with intense transmission

G. , , 1996.

, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva, World Health Organization, 2003.

. Who/mmv, Methods and techniques for clinical trials on antimalarial drug efficacy: Genotyping to identify parasite populations. Geneva, World Health Organization, 2008.

N. J. White, K. Stepniewska, K. Barnes, R. N. Price, and J. Simpson, Simplified antimalarial therapeutic monitoring: using the day-7 drug level?, Trends Parasitol, vol.24, pp.159-63, 2008.

, Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies. Geneva, World Health Organization, 2011.

L. Konaté, J. Zwetyenga, C. Rogier, E. Bischoff, D. Fontenille et al., Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions, Trans R Soc Trop Med Hyg, vol.93, issue.1, pp.21-29, 1999.

B. Greenhouse, C. Dokomajilar, A. Hubbard, P. J. Rosenthal, and G. Dorsey, Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials, Antimicrob Agents Chemother, vol.51, pp.3096-103, 2007.

K. Mugittu, M. Adjuik, G. Snounou, F. Ntoumi, W. Taylor et al., Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness, Trop Med Int Health, vol.11, pp.1350-1359, 2006.

C. Messerli, N. E. Hofmann, H. Beck, and I. Felger, Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers, Antimicrob Agents Chemother, vol.61, pp.1500-1516, 2017.

B. Greenhouse, A. Myrick, C. Dokomajilar, J. M. Woo, E. J. Carlson et al., Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections, Am J Trop Med Hyg, vol.75, pp.836-878, 2006.

N. Falk, N. Maire, W. Sama, S. Owusu-agyei, T. Smith et al., Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum, Am J Trop Med Hyg, vol.74, pp.944-50, 2006.

A. Liljander, L. Wiklund, N. Falk, M. Kweku, A. Mårtensson et al., Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2), Malar J, vol.8, p.78, 2009.

P. Orjuela-sánchez, M. C. Brandi, and M. U. Ferreira, Microsatellite analysis of malaria parasites, Methods Mol Biol, vol.1006, pp.247-58, 2013.

T. J. Anderson, B. Haubold, J. T. Williams, J. G. Estrada-franco, L. Richardson et al., Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum, Mol Biol Evol, vol.17, pp.1467-82, 2000.

R. Abdul-ghani, A. Mt, A. -. Shibani, L. A. Allam, and A. F. , A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs, Acta Trop, vol.137, pp.44-57, 2014.

A. Nyachieo, C. Van-overmeir, T. Laurent, J. Dujardin, D. '-alessandro et al., Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections, Am J Trop Med Hyg, vol.73, pp.210-213, 2005.

R. Daniels, S. K. Volkman, D. A. Milner, M. N. Neafsey, D. E. Park et al., A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking, Malar J, vol.7, p.223, 2008.

M. K. Laufer, A. A. Djimdé, and C. V. Plowe, Monitoring and deterring drugresistant malaria in the era of combination therapy, Am J Trop Med Hyg, vol.77, pp.160-169, 2007.

M. K. Laufer, Monitoring antimalarial drug efficacy: current challenges, Curr Infect Dis Rep, vol.11, pp.59-65, 2009.

N. J. White, Assessment of the pharmacodynamic properties of antimalarial drugs in vivo, Antimicrob Agents Chemother, vol.41, pp.1413-1435, 1997.

N. J. White, Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization, Antimicrob Agents Chemother, vol.57, pp.5792-807, 2013.

N. J. White, Antimalarial pharmacokinetics and treatment regimens, Br J Clin Pharmacol, vol.34, pp.1-10, 1992.

P. Wwarn)-lumefantrine and . Group, Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and metaanalysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data, BMC Med, vol.13, p.227, 2015.

R. M. Hoglund, L. Workman, M. D. Edstein, N. X. Thanh, N. N. Quang et al., Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis, PLoS Med, vol.14, p.1002212, 2017.

W. Trager and J. B. Jensen, Human malaria parasites in continuous culture, Science, vol.193, pp.673-678, 1976.

B. Witkowski, C. Amaratunga, N. Khim, S. Sreng, P. Chim et al., Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drugresponse studies, Lancet Infect Dis, vol.13, pp.1043-1052, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00863935

R. Kumar, A. Musiyenko, S. Barik, and J. Malar, , vol.2, p.30, 2003.

C. J. Woodrow, S. Dahlström, R. Cooksey, J. A. Flegg, L. Nagard et al., High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool, Antimicrob Agents Chemother, vol.57, pp.3121-3151, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00861904

L. K. Basco and E. Heseltine, World Health Organization. Field application of in vitro assays sensitivity of human malaria parasites antimalarial drugs. Geneva: World Health Organization, 2007.

K. H. Rieckmann, G. H. Campbell, L. J. Sax, and J. E. Mrema, Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique, Lancet, vol.1, pp.22-25, 1978.

, In vitro micro-test (mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin. Geneva, World Health Organization, 2001.

R. E. Desjardins, C. J. Canfield, J. D. Haynes, and J. D. Chulay, Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique, Antimicrob Agents Chemother, vol.16, pp.710-718, 1979.

J. D. Chulay, J. D. Haynes, and C. L. Diggs, Plasmodium falciparum: assessment of in vitro growth by [3H] hypoxanthine incorporation, Exp Parasitol, vol.55, pp.138-184, 1983.

M. T. Makler and D. J. Hinrichs, Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia, Am J Trop Med Hyg, vol.48, pp.205-215, 1993.

M. T. Makler, J. M. Ries, J. A. Williams, J. E. Bancroft, R. C. Piper et al., Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity, Am J Trop Med Hyg, vol.48, pp.739-780, 1993.

H. Noedl, W. H. Wernsdorfer, R. S. Miller, and C. Wongsrichanalai, Histidine-rich protein II: a novel approach to malaria drug sensitivity testing, Antimicrob Agents Chemother, vol.46, pp.1658-64, 2002.

P. Brasseur, P. Agnamey, A. Moreno, and P. Druilhe, Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest), Med Trop, vol.61, pp.545-552, 2001.

H. Noedl, W. H. Wernsdorfer, H. Kollaritsch, S. Looareesuwan, R. S. Miller et al., Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives, Wien Klin Wochenschr, vol.115, pp.23-30, 2003.

J. D. Johnson, R. A. Dennull, L. Gerena, M. Lopez-sanchez, N. E. Roncal et al., Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother, vol.51, pp.1926-1959, 2007.

K. Pattanapanyasat, S. Thaithong, D. E. Kyle, R. Udomsangpetch, K. Yongvanitchit et al., Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria, Cytometry, vol.27, pp.84-91, 1997.

G. Wirjanata, I. Handayuni, P. Prayoga, D. Apriyanti, F. Chalfein et al., Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry, Malar J, vol.14, p.417, 2015.

C. J. Woodrow, C. Wangsing, K. Sriprawat, P. R. Christensen, F. Nosten et al., Comparison between flow cytometry, microscopy, and lactate dehydrogenase-based enzyme-linked immunosorbent assay for Plasmodium falciparum drug susceptibility testing under field conditions, J Clin Microbiol, vol.53, pp.3296-303, 2015.

B. Witkowski, N. Khim, P. Chim, S. Kim, S. Ke et al., Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia, Antimicrob Agents Chemother, vol.57, pp.914-937, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02378668

B. Witkowski, J. Lelievre, M. J. Lopez-barragan, V. Laurent, X. Z. Su et al., Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism, Antimicrob Agents Chemother, vol.54, pp.1872-1879, 2010.

C. Amaratunga, A. T. Neal, and R. M. Fairhurst, Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay, Antimicrob Agents Chemother, vol.58, pp.4938-4978, 2014.

S. Picot, P. Olliaro, F. De-monbrison, A. Bienvenu, R. N. Price et al., A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malar J, vol.8, p.89, 2009.

S. J. Foote, D. E. Kyle, R. K. Martin, A. Oduola, K. Forsyth et al., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, vol.345, pp.255-263, 1990.

D. A. Fidock, T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov et al., Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, vol.6, pp.861-71, 2000.

A. Djimdé, O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo et al., A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med, vol.344, pp.257-63, 2001.

D. S. Peterson, W. K. Milhous, and T. E. Wellems, Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria, Proc Natl Acad Sci USA, vol.87, pp.3018-3040, 1990.

J. C. Reeder, K. H. Rieckmann, B. Genton, K. Lorry, B. Wines et al., Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea, Am J Trop Med Hyg, vol.55, pp.209-222, 1996.

P. Wang, M. Read, P. F. Sims, and J. E. Hyde, Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Mol Microbiol, vol.23, pp.979-86, 1997.

A. F. Cowman, D. Galatis, and J. K. Thompson, Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine, Proc Natl Acad Sci, vol.91, pp.1143-1150, 1994.

R. N. Price, A. Uhlemann, A. Brockman, R. Mcgready, A. E. Phaipun et al., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, pp.438-485, 2004.

M. Korsinczky, N. Chen, B. Kotecka, A. Saul, K. Rieckmann et al., Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site, Antimicrob Agents Chemother, vol.44, pp.2100-2108, 2000.

B. Witkowski, V. Duru, N. Khim, L. S. Ross, B. Saintpierre et al., A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, pp.174-83, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01400955

R. Amato, P. Lim, O. Miotto, C. Amaratunga, D. Dek et al., Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotypephenotype association study, Lancet Infect Dis, vol.17, pp.164-73, 2017.

R. Mann, S. Sharma, N. Mishra, N. Valecha, and A. R. Anvikar, Comparative assessment of genomic DNA extraction processes for Plasmodium: identifying the appropriate method, J Vector Borne Dis, vol.52, pp.273-80, 2015.

M. T. Duraisingh, J. Curtis, and D. C. Warhurst, Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion, Exp Parasitol, vol.89, pp.1-8, 1998.

P. De-eldin-pécoulas, L. K. Basco, B. Abdallah, M. K. Djé, L. Bras et al., Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion, Exp Parasitol, vol.80, pp.483-490, 1995.

F. Sanger, S. Nicklen, and A. R. Coulson, DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci USA, vol.74, pp.5463-5470, 1977.

O. Miotto, R. Amato, E. A. Ashley, B. Macinnis, J. Almagro-garcia et al., Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nat Genet, vol.47, pp.226-260, 2015.

S. M. Taylor, C. M. Parobek, N. Aragam, B. E. Ngasala, A. Mårtensson et al., Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes, J Infect Dis, vol.208, pp.1998-2006, 2013.

L. Henden, S. Lee, I. Mueller, A. Barry, and M. Bahlo, Detecting selection signals in Plasmodium falciparum using identity-by-descent analysis, BioRxiv, 2016.

M. Chavchich, L. Gerena, J. Peters, N. Chen, Q. Cheng et al., Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum, Antimicrob Agents Chemother, vol.54, pp.2455-64, 2010.

A. Purfield, A. Nelson, A. Laoboonchai, K. Congpuong, P. Mcdaniel et al., A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR, Malar J, vol.3, p.9, 2004.

N. P. Leclair, M. D. Conrad, F. N. Baliraine, C. Nsanzabana, S. L. Nsobya et al., Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum, J Clin Microbiol, vol.51, pp.2564-70, 2013.

A. Moers, R. L. Hallett, R. Burrow, H. Schallig, C. J. Sutherland et al., Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay, Antimicrob Agents Chemother, vol.59, pp.365-71, 2015.

. Quantumdx, , 2017.

C. W. Hunja, H. Unger, P. E. Ferreira, R. Lumsden, S. Morris et al., Travellers as sentinels: assaying the worldwide distribution of polymorphisms associated with artemisinin combination therapy resistance in Plasmodium falciparum using malaria cases imported into Scotland, Int J Parasitol, vol.43, pp.885-894, 2013.

M. Gharbi, J. A. Flegg, V. Hubert, E. Kendjo, J. E. Metcalf et al., Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, Malar J, vol.12, p.35, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00795004

C. Sibley, K. I. Barnes, and C. V. Plowe, The rationale and plan for creating a World Antimalarial Resistance Network (WARN), Malar J, vol.6, p.118, 2007.

C. H. Sibley, P. J. Guerin, and P. Ringwald, Monitoring antimalarial resistance: launching a cooperative effort, Trends Parasitol, vol.26, pp.221-225, 2010.

. Who/tdr, Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings. Geneva, World Health Organization, 2015.

D. K. Das, R. Mukherjee, and C. Chakraborty, Computational microscopic imaging for malaria parasite detection: a systematic review, J Microsc, vol.260, pp.1-19, 2015.

B. Srivastava, A. R. Anvikar, S. K. Ghosh, N. Mishra, N. Kumar et al., Computer-vision-based technology for fast, accurate and cost effective diagnosis of malaria, Malar J, vol.14, p.526, 2015.

Y. Eshel, A. Houri-yafin, H. Benkuzari, N. Lezmy, M. Soni et al., Evaluation of the Parasight Platform for Malaria Diagnosis, J. Clin. Microbiol, vol.55, pp.768-75, 2017.

W. J. Collins, B. Greenhouse, P. J. Rosenthal, and G. Dorsey, The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005, Malar J, vol.5, p.122, 2006.

M. M. Plucinski, L. Morton, M. Bushman, P. R. Dimbu, and V. Udhayakumar, Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping, Antimicrob Agents Chemother, vol.59, pp.6096-100, 2015.

H. Noedl, C. Wongsrichanalai, and W. H. Wernsdorfer, Malaria drug-sensitivity testing: new assays, new perspectives, Trends Parasitol, vol.19, pp.175-81, 2003.

M. H. Alin, C. M. Kihamia, A. Bjorkman, B. A. Bwijo, Z. Premji et al., Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine, Am J Trop Med Hyg, vol.53, pp.639-684, 1995.

K. Singh, A. Agarwal, S. I. Khan, L. A. Walker, and B. L. Tekwani, Growth, drug susceptibility, and gene expression profiling of Plasmodium falciparum cultured in medium supplemented with human serum, J Biomol Screen, vol.12, pp.1109-1123, 2007.

E. K. Mberu, M. K. Mosobo, A. M. Nzila, G. O. Kokwaro, C. H. Sibley et al., The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya, Am J Trop Med Hyg, vol.62, pp.396-401, 2000.

W. Chaijaroenkul, N. Bangchang, K. Mungthin, M. Ward, and S. A. , In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003, Malar J, vol.4, p.37, 2005.

S. Chaorattanakawee, S. D. Tyner, C. Lon, K. Yingyuen, W. Ruttvisutinunt et al., Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia, Malar J, vol.12, p.239, 2013.

D. J. Bacon, C. Latour, C. Lucas, O. Colina, P. Ringwald et al., Comparison of a SYBR green I-based assay with a histidine-rich protein II enzymelinked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates, Antimicrob Agents Chemother, vol.51, pp.1172-1180, 2007.

R. Bhatia, A. Gautam, S. K. Gautam, D. Mehta, V. Kumar et al., Assessment of SYBR green I dye-based fluorescence assay for screening antimalarial activity of cationic peptides and DNA intercalating agents, Antimicrob Agents Chemother, vol.59, pp.2886-2895, 2015.

M. Smilkstein, N. Sriwilaijaroen, J. X. Kelly, P. Wilairat, and M. Riscoe, Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening, Antimicrob Agents Chemother, vol.48, pp.1803-1809, 2004.

A. Schwartz, A. Baidjoe, P. J. Rosenthal, G. Dorsey, T. Bousema et al., The effect of storage and extraction methods on amplification of Plasmodium falciparum DNA from dried blood spots, Am J Trop Med Hyg, vol.92, pp.922-927, 2015.

P. Muhamad, W. Chaijaroenkul, K. Congpuong, N. -. Bangchang, and K. , SYBR green I and Taqman quantitative real-time polymerase chain reaction methods for the determination of amplification of Plasmodium falciparum multidrug resistance-1 gene (PFMDR1), J Parasitol, vol.97, pp.939-981, 2011.

E. A. Achidi, T. Agbenyega, S. Allen, O. Amodu, K. Bojang et al., A global network for investigating the genomic epidemiology of malaria, Nature, vol.456, pp.732-739, 2008.

, Genomic epidemiology of artemisinin resistant malaria, MalariaGEN Plasmodium falciparum Community Project, 2016.

, Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience, Trop Med Int Health, vol.6, pp.891-899, 2001.

, The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy, Trop Med Int Health, vol.8, pp.860-867, 2003.

. Who/paho and . Paho-usaid, Partnership to fight malaria in the Amazon, 2017.

E. S. Halsey, M. Venkatesan, M. M. Plucinski, E. Talundzic, N. W. Lucchi et al., Capacity development through the US President's malaria initiative-supported antimalarial resistance monitoring in Africa network. Emerg Infect Dis, 2017.